Recent papers
(click on journal logo to download, click on
scholar_logo_lg_2011 to get citations)
2012-107
Schaefer M, Sarkar R, Weich V, Effenberger S, Friebe A, Heinze L, Spengler U, Schlaepfer T, Reimer J, Buggisch P, Ockenga J, Link R, Rentrop M, Weidenbach H, Discher T, Fromm G, Lieb K, Baumert T, Heinz A, Zeuzem S, Berg T (2010): Escitalopram for the Prevention of Peginterferon Alfa-2a and Ribavirin Associated Depression in HCV-infected patients. Annals of Internal Medicine 157:94-103.
2012- 118
Holtzheimer PE, 3rd, Kosel M, Schlaepfer T (2012): Brain stimulation therapies for neuropsychiatric disease. Handb Clin Neurol 106:681-95.
2012-111
Bewernick B, Kayser S, Sturm V, Schlaepfer TE (2012): Long-Term Effects of Nucleus Accumbens Deep Brain Stimulation in Treatment-Resistant Depression: Evidence for Sustained Efficacy. Neuropschopharmacology doi:10.1038/npp.2012.44.
2012-117
Schlaepfer TE, Nemeroff CB (2012): Preface. Handb Clin Neurol 106:ix-x.
2012-113
Schläpfer TE, Kayser S (2012): Stimulationsverfahren: Transkranielle Magnetstimulation, Magnetkrampftherapie und Tiefe Hirnstimulation. Nervenarzt 83:95-105.
2012-112
Synofzyk M, Schlaepfer TE, Fins JJ (2012): How happy is too happy? Euphoria, Neuroethics and Deep Brain Stimulation of the Nucleus Accumbens. The American Journal of Bioethics 3:30-36.
2012-114
Schlaepfer TE (2012): Towards an Emergent Consensus - International Perspectives on Neuroethics of Deep Brain Stimulation for Psychiatric Disorders - A Tower of Babel? The American Journal of Bioethics 3:1-3..
2012-110
Becker B, Mihov Y, Scheele D, Kendrick K, Aydin M, Matusch A, Kunz W, Reich H, Schlaepfer TE, Maier W, Hurlemann R (2012): Fear processing and social networking without a functional amygdala. Biol Psychiatry Jan 2. [Epub ahead of print].
2011-108
Synofzyk M, Fins J, Schlaepfer T (2011): A Neuromodulation Experience Registry for Deep Brain Stimulation studies in psychiatric research: A Rationale and Recommendations for Implementation. Brainstimulation dx.doi.org/10.1016/j.brs.2011.10.003.
2011-109
Goodwin G, Abbar M, Schlaepfer TE, Grunze H, Licht R, Belevier F, Fountoulakis K, Altamura C, Pitchot W, Agren H, Holsboer-Trachsler E, Vieta E (2011): Aripiprazole in Patients with Bipolar Disorder and Beyond: An Update of Practical Guidance. Current Medical Research & Opinion [Epub ahead of print].
2012-106
Schlaepfer TE, Ågren H, Monteleone P, Gasto C, Pitchot W, Rouillon F, Nutt D, Kasper S (2012): The hidden third: improving outcome in treatment-resistant depression. Journal of Psychopharmacology DOI: 10.1177/0269881111431748.
2011-104
Grubert C, Hurlemann R, Bewernick BH, Kayser S, Hadrysiewicz B, Axmacher N, Sturm V, Schlaepfer TE (2011): Neuropsychological safety of nucleus accumbens deep brain stimulation for major depression: effects of 12-month stimulation. World J Biol Psychiatry 12:516-27.
2011-105
Schlaepfer TE, Bewernick B, Kayser S, Lenz D (2011): Modulating affect, cognition, and behavior - prospects of deep brain stimulation for treatment-resistant psychiatric disorders. Front Integr Neurosci 5:29.
2011-103
Schlaepfer TE, Saviane C (2011): Special Topic: The development of deep brain stimulation for neurological and psychiatric disorders: clinical, societal and ethical issues. Frontiers in Integrative Neuroscience 5.
Link: Frontiers in Integrative Neuroscience | Special Topics
2011-099
Fins JJ, Schlaepfer TE, Nuttin B, Kubu CS, Galert T, Sturm V, Merkel R, Mayberg HS (2011): Ethical guidance for the management of conflicts of interest for researchers, engineers and clinicians engaged in the development of therapeutic deep brain stimulation. J Neural Eng 8:033001.
20111-100
Onur OA, Patin A, Mihov Y, Buecher B, Stoffel-Wagner B, Schlaepfer TE, Walter H, Maier W, Hurlemann R (2011): Overnight deprivation from smoking disrupts amygdala responses to fear. Hum Brain Mapp 10.1002/hbm.21293.
2011-097
Wade AG, Crawford GM, Nemeroff CB, Schatzberg AF, Schlaepfer T, McConnachie A, Haazen L, Buntinx E (2011): Citalopram plus low-dose pipamperone versus citalopram plus placebo in patients with major depressive disorder: an 8-week, double-blind, randomized study on magnitude and timing of clinical response. Psychological Medicine 41:2089-97.
2010-075
Bewernick BH, Hurlemann R, Matusch A, Kayser S, Grubert C, Hadrysiewicz B, Axmacher N, Lemke M, Cooper-Mahkorn D, Cohen MX, Brockmann H, Lenartz D, Sturm V, Schlaepfer TE (2010): Nucleus accumbens deep brain stimulation decreases ratings of depression and anxiety in treatment-resistant depression. Biol Psychiatry 67:110-6
.scholar_logo_lg_2011
2008-086
Synofzik M, Schlaepfer TE (2008): Stimulating personality: ethical criteria for deep brain stimulation in psychiatric patients and for enhancement purposes. Biotechnol J 3:1511-20.
scholar_logo_lg_2011
2010-064
Schlaepfer TE, Cohen MX, Frick C, Kosel M, Brodesser D, Axmacher N, Joe AY, Kreft M, Lenartz D, Sturm V (2008): Deep brain stimulation to reward circuitry alleviates anhedonia in refractory major depression. Neuropsychopharmacology 33:368-77.
scholar_logo_lg_2011
1994-007
Schlaepfer TE, Harris GJ, Tien AY, Peng LW, Lee S, Federman EB, Chase GA, Barta PE, Pearlson GD (1994): Decreased regional cortical gray matter volume in schizophrenia. American Journal of Psychiatry 151:842-848.
scholar_logo_lg_2011
2005-055
Schlaepfer TE, Lieb K (2005): Deep brain stimulation for treatment of refractory depression. Lancet 366:1420-2.
scholar_logo_lg_2011